Aurobindo to acquire Apotex ops in 5 European nations for EUR 74 mn
New Delhi: Aurobindo Pharma on Saturday said it has inked a pact to acquire Apotex's commercial operations across five European countries, including Poland and Spain, for 74 million euros.
The acquisition is in line with the company's strategy to strengthen and grow its European business and to expand in Eastern Europe, Aurobindo Pharma said in a statement.
The Hyderabad-based drug firm has inked definitive agreement to acquire from Apotex International Inc its commercial operations and certain supporting infrastructure in five European countries, it added.
As part of the deal, Aurobindo would acquire commercial infrastructure including personnel, products, marketing authorisations and dossier license rights in Poland, the Czech Republic, the Netherlands (including a manufacturing facility in Leiden), Spain and Belgium.
In Poland, Aurobindo will add significant sales based on the established brand name APO as well as a dedicated sales force covering physicians and the pharmacy network.